Secretion of glycated insulin from pancreatic β-cells in diabetes represents a novel aspect of β-cell dysfunction and glucose toxicity

Diabetes and Metabolism

Volumn 28, Issue 6 II, 2002, Pages

  McKillop, A M ^a   Abdel Wahab, Y H A ^b   Mooney, M H ^b   O'Harte, F P M ^b   Flatt, P R ^b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b NONE

Author keywords

Defective insulin action; Defective insulin secretion; Diabetes; Glycated insulin; Glycation; Insulin; Pancreatic cell

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY;

AMINO ACID SEQUENCE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; GLYCOSYLATION; HUMANS; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MICE; MOLECULAR SEQUENCE DATA;

EID: 12244304179     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Flatt PR, Bailey CJ, Berggren PO, Herberg L, Swanston-Flatt SK. Defective insulin secretion in diabetes and insulinoma. In: Flatt PR, eds. "Nutrient Regulation of Insulin Secretion" Portland Press, London. 1992, 341-386.
2. Flatt PR, Abdel-Wahab YHA, Wilson AM, Barnett CR, O'Harte FPM, Swanston-Flatt SK. Site-specific defects and glucose toxicity in pancreatic β-cell dysfunction in non-insulin-dependent diabetes mellitus. In: Flatt PR, Lenzen S, eds. "Frontiers of Insulin Secretion and Pancreatic β-Cell Research" Smith-Gordon & Co. Ltd, London. 1994, 481-489.
3. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous lean (obl+) mice. Diabetologia, 1981, 20, 573-577.
4. Leahy JL. Natural history of β-cell dysfunction in NIDDM. Diabetes Care, 1990, 13, 992-1010.
5. Simonson DC, Rossetti L, Giaccari A, Defronzo RA. Glucose toxicity. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P. eds. "International Textbook of Diabetes" Chichester: John Wiley. 1992, 635-667.
6. Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications of the management of diabetes. Diabetologia, 1985, 28, 119-121.
7. Bedoya FJ, Jeanrenaud B. Evolution of insulin secretory response to glucose by perfused islets from lean (fa/fa) rats chronically infused with glucose. Diabetes, 1991, 40, 7-14.
8. Kaiser N, Corcos AP, Sarel I, Cerasi E. Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of β-cell function by chronic exposure to high glucose. Endocrinology, 1991, 129, 2067-2076.
9. Davalli AM, Ricordi C, Socci C, et al. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: Evidence supporting specific desensitization rather than β-cell exhaustion. J Clin Endocrinol Metabol, 1992, 74, 790-794.
10. Eizirik EL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest, 1992, 90, 1263-1268.
11. Svensson C, Sandler S, Hellerstrom C. Lack of long term β-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the β-cells to hyperglycaemia in vivo. J Endocrinol, 1993, 136, 289-296.
12. McClenaghan NH, Barnett CR, Ah-Sing E, et al. Characterisation of a novel glucose-responsive insulin-secreting cell line BRIN-BD11, produced by electrofusion. Diabetes, 1996, 45, 1132-1140.
13. Abdel-Wahab YHA, O'Harte FPM, Ratcliff H, McClenaghan NH, Barnett CR, Flatt PR. Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes, 1996, 45, 1489-1496.
14. Abdel-Wahab YHA, O'Harte FPM, Boyd AC, Barnett CR, Flatt PR. Glycation of insulin results in reduced biological activity in mice. Acta Diabetologica, 1997, 34, 265-270.
15. Boyd AC, Abdel-Wahab YHA, McKillop AM, et al. Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle. Biochim Biophys Acta, 2000, 1523, 128-134.
16. O'Harte FPM, Boyd AC, McKillop AM, et al. Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin. Peptides, 2000, 21, 1519-1526.
17. Brownlee M, Cerami A, Vlassara H. Advanced products of non-enzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev, 1988, 4, 437-451.
18. Brownlee M. The pathological implications of protein glycation. Clin Invest Med, 1995, 18, 275-281.
19. Lyons TJ, Jenkins AJ. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Reviews, 1997, 5, 365-391.
20. Abdel-Wahab YHA, O'Harte FPM, Barnett CR, Flatt PR. Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture. J Endocrinol, 1997, 152, 59-67.
21. O'Harte FPM, Højrup P, Barnett CR, Flatt PR. Identification of the site of glycation of human insulin. Peptides, 1996, 17, 1323-1330.
22. McKillop AM, McCluskey JT, Boyd AC, Mooney MH, Flatt PR, O'Harte FPM. Production and characterization of specific antibodies for evaluation of glycated insulin in plasma and biological tissues. J Endocrinol, 2000, 167, 153-163.
23. Avigad G, Kniep A, Bailin G. Reaction of rabbit skeletal myosin with D-glucose 6-phosphate. Biochem Mol Biol Int, 1996, 40, 273-284.
24. O'Harte FPM, Penney AC, Flatt PR. Glycation of insulin by phosphorylated and non-phosphorylated reducing sugars. [Abstract] Biochem Soc Trans, 1997, 25, 150S.
25. McKillop AM, Mooney MN, Harriott P, Flatt PR, O'Harte FPM. Evaluation of glycated insulin in diabetic animals using immunocytochemistry and radioimmunoassay. Biochem Biophys Res Comm, 2001, 286, 524-528.
26. McKillop AM, McGurk C, McCluskey JT, et al. Detection of glycated insulin in plasma of type 2 diabetic subjects. [Abstract] Digestion, 1999, 60, 507.
27. O'Harte FPM, McKillop AM, Mooney MH, Flatt PR. Development and use of a specific radioimmunoassay for detection of glycated insulin in diabetes. [Abstract] Diabetologia, 2000, 43 (Suppl. 1), A52.
28. Seminoff LA, Gleeson JM, Zheng J, et al. A self regulating insulin delivery system. 2. In vivo characteristics of synthetic glycosylated insulin. Int J Pharm, 1989, 54, 251-257.
29. Dolhofer R, Wieland OH. Preparation and biological properties of glycosylated insulin. FEBS Letters, 1979, 100, 133-136.
30. Lapolla A, Tessari P, Poli T, et al. Reduced in vivo biological activity of in vitro glycosylated insulin. Diabetes, 1988, 37, 787-791.
31. Hunter SJ, Boyd AC, O'Harte FPM, et al. Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycaemic clamp technique in man. Diabetes (in press).